GUILLERMO GARCIA-MANERO to Leukemia, Experimental
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Leukemia, Experimental.
Connection Strength
0.117
-
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. Leukemia. 2008 Jun; 22(6):1117-24.
Score: 0.080
-
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition. Leukemia. 2017 10; 31(10):2143-2150.
Score: 0.037